Abstract
BACKGROUND: Creutzfeldt-Jakob disease (CJD) is a prion disease which is manifest as a sporadic, inherited, and transmissible neurodegenerative disorder. The mean age at onset of CJD is approximately 60 years, and as such, many people destined to succumb undoubtedly die of other illnesses first. The delayed onset of CJD has complicated the analysis of inherited forms of the illness and led to the suggestion that mutations in the prion protein (PrP) gene are necessary but not sufficient for prion disease despite genetic linkage; indeed, an environmental factor such as a ubiquitous virus has been proposed as a second necessary factor. MATERIALS AND METHODS: To examine what appeared to be incomplete penetrance, we applied a life-table analysis to clinical and pedigree data from a cluster population of Libyan Jews in which the E200K mutation is prevalent. The study population included 42 affected and 44 unaffected members of 13 Libyan Jewish families, all of whom possessed the E200K mutation. RESULTS: The calculated value using life table analysis is 0.77 at age 70 which increases to 0.89 if a mutation carrier survives to age 80 and 0.96 if age 80 is surpassed. CONCLUSIONS: These data argue that the E200K mutation alone is sufficient to cause prion disease and does so in an age-dependent manner.
Full text
PDF






Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Amouyel P., Vidal O., Launay J. M., Laplanche J. L. The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. The French Research Group on Epidemiology of Human Spongiform Encephalopathies. Lancet. 1994 Nov 12;344(8933):1315–1318. doi: 10.1016/s0140-6736(94)90691-2. [DOI] [PubMed] [Google Scholar]
- Baker H. E., Poulter M., Crow T. J., Frith C. D., Lofthouse R., Ridley R. M. Aminoacid polymorphism in human prion protein and age at death in inherited prion disease. Lancet. 1991 May 25;337(8752):1286–1286. doi: 10.1016/0140-6736(91)92953-y. [DOI] [PubMed] [Google Scholar]
- Baker H. F., Ridley R. M., Crow T. J. Experimental transmission of an autosomal dominant spongiform encephalopathy: does the infectious agent originate in the human genome? Br Med J (Clin Res Ed) 1985 Aug 3;291(6491):299–302. doi: 10.1136/bmj.291.6491.299. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brown P., Goldfarb L. G., Kovanen J., Haltia M., Cathala F., Sulima M., Gibbs C. J., Jr, Gajdusek D. C. Phenotypic characteristics of familial Creutzfeldt-Jakob disease associated with the codon 178Asn PRNP mutation. Ann Neurol. 1992 Mar;31(3):282–285. doi: 10.1002/ana.410310309. [DOI] [PubMed] [Google Scholar]
- Chapman J., Ben-Israel J., Goldhammer Y., Korczyn A. D. The risk of developing Creutzfeldt-Jakob disease in subjects with the PRNP gene codon 200 point mutation. Neurology. 1994 Sep;44(9):1683–1686. doi: 10.1212/wnl.44.9.1683. [DOI] [PubMed] [Google Scholar]
- Chesebro B., Caughey B. Scrapie agent reflication without the prion protein? Curr Biol. 1993 Oct 1;3(10):696–698. doi: 10.1016/0960-9822(93)90072-v. [DOI] [PubMed] [Google Scholar]
- Chesebro B. Spongiform encephalopathies. PrP and the scrapie agent. Nature. 1992 Apr 16;356(6370):560–560. doi: 10.1038/356560a0. [DOI] [PubMed] [Google Scholar]
- Collinge J., Palmer M. S., Dryden A. J. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet. 1991 Jun 15;337(8755):1441–1442. doi: 10.1016/0140-6736(91)93128-v. [DOI] [PubMed] [Google Scholar]
- Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993 Aug 13;261(5123):921–923. doi: 10.1126/science.8346443. [DOI] [PubMed] [Google Scholar]
- Diringer H. Transmissible spongiform encephalopathies (TSE) virus-induced amyloidoses of the central nervous system (CNS). Eur J Epidemiol. 1991 Sep;7(5):562–566. doi: 10.1007/BF00143140. [DOI] [PubMed] [Google Scholar]
- Easton D. F., Ponder M. A., Cummings T., Gagel R. F., Hansen H. H., Reichlin S., Tashjian A. H., Jr, Telenius-Berg M., Ponder B. A. The clinical and screening age-at-onset distribution for the MEN-2 syndrome. Am J Hum Genet. 1989 Feb;44(2):208–215. [PMC free article] [PubMed] [Google Scholar]
- Evans D. A., Funkenstein H. H., Albert M. S., Scherr P. A., Cook N. R., Chown M. J., Hebert L. E., Hennekens C. H., Taylor J. O. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA. 1989 Nov 10;262(18):2551–2556. [PubMed] [Google Scholar]
- Gabizon R., Rosenman H., Meiner Z., Kahana I., Kahana E., Shugart Y., Ott J., Prusiner S. B. Mutation in codon 200 and polymorphism in codon 129 of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease. Philos Trans R Soc Lond B Biol Sci. 1994 Mar 29;343(1306):385–390. doi: 10.1098/rstb.1994.0033. [DOI] [PubMed] [Google Scholar]
- Gabizon R., Rosenmann H., Meiner Z., Kahana I., Kahana E., Shugart Y., Ott J., Prusiner S. B. Mutation and polymorphism of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease (CJD). Am J Hum Genet. 1993 Oct;53(4):828–835. [PMC free article] [PubMed] [Google Scholar]
- Goldfarb L. G., Mitrová E., Brown P., Toh B. K., Gajdusek D. C. Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob disease in Slovakia. Lancet. 1990 Aug 25;336(8713):514–515. doi: 10.1016/0140-6736(90)92073-q. [DOI] [PubMed] [Google Scholar]
- Herzberg L., Herzberg B. N., Gibbs C. J., Jr, Sullivan W., Amyx H., Gajdusek D. C. Letter: Creutzfeldt-Jakob disease: hypothesis for high incidence in Libyan Jews in Israel. Science. 1974 Nov 29;186(4166):848–848. doi: 10.1126/science.186.4166.848. [DOI] [PubMed] [Google Scholar]
- Hsiao K., Baker H. F., Crow T. J., Poulter M., Owen F., Terwilliger J. D., Westaway D., Ott J., Prusiner S. B. Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome. Nature. 1989 Mar 23;338(6213):342–345. doi: 10.1038/338342a0. [DOI] [PubMed] [Google Scholar]
- Hsiao K., Meiner Z., Kahana E., Cass C., Kahana I., Avrahami D., Scarlato G., Abramsky O., Prusiner S. B., Gabizon R. Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease. N Engl J Med. 1991 Apr 18;324(16):1091–1097. doi: 10.1056/NEJM199104183241604. [DOI] [PubMed] [Google Scholar]
- Kahana E., Alter M., Braham J., Sofer D. Creutzfeldt-jakob disease: focus among Libyan Jews in Israel. Science. 1974 Jan 11;183(4120):90–91. doi: 10.1126/science.183.4120.90. [DOI] [PubMed] [Google Scholar]
- Kahana E., Zilber N., Abraham M. Do Creutzfeldt-Jakob disease patients of Jewish Libyan origin have unique clinical features? Neurology. 1991 Sep;41(9):1390–1392. doi: 10.1212/wnl.41.9.1390. [DOI] [PubMed] [Google Scholar]
- Kieburtz K., MacDonald M., Shih C., Feigin A., Steinberg K., Bordwell K., Zimmerman C., Srinidhi J., Sotack J., Gusella J. Trinucleotide repeat length and progression of illness in Huntington's disease. J Med Genet. 1994 Nov;31(11):872–874. doi: 10.1136/jmg.31.11.872. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kitamoto T., Iizuka R., Tateishi J. An amber mutation of prion protein in Gerstmann-Sträussler syndrome with mutant PrP plaques. Biochem Biophys Res Commun. 1993 Apr 30;192(2):525–531. doi: 10.1006/bbrc.1993.1447. [DOI] [PubMed] [Google Scholar]
- Kitamoto T., Tateishi J. Human prion diseases with variant prion protein. Philos Trans R Soc Lond B Biol Sci. 1994 Mar 29;343(1306):391–398. doi: 10.1098/rstb.1994.0034. [DOI] [PubMed] [Google Scholar]
- Newcombe R. G. A life table for onset of Huntington's chorea. Ann Hum Genet. 1981 Oct;45(Pt 4):375–385. doi: 10.1111/j.1469-1809.1981.tb00351.x. [DOI] [PubMed] [Google Scholar]
- Palmer M. S., Dryden A. J., Hughes J. T., Collinge J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature. 1991 Jul 25;352(6333):340–342. doi: 10.1038/352340a0. [DOI] [PubMed] [Google Scholar]
- Petersen R. B., Tabaton M., Berg L., Schrank B., Torack R. M., Leal S., Julien J., Vital C., Deleplanque B., Pendlebury W. W. Analysis of the prion protein gene in thalamic dementia. Neurology. 1992 Oct;42(10):1859–1863. doi: 10.1212/wnl.42.10.1859. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pocchiari M., Salvatore M., Cutruzzolá F., Genuardi M., Allocatelli C. T., Masullo C., Macchi G., Alemá G., Galgani S., Xi Y. G. A new point mutation of the prion protein gene in Creutzfeldt-Jakob disease. Ann Neurol. 1993 Dec;34(6):802–807. doi: 10.1002/ana.410340608. [DOI] [PubMed] [Google Scholar]
- Ponder B. A., Ponder M. A., Coffey R., Pembrey M. E., Gagel R. F., Telenius-Berg M., Semple P., Easton D. F. Risk estimation and screening in families of patients with medullary thyroid carcinoma. Lancet. 1988 Feb 20;1(8582):397–401. doi: 10.1016/s0140-6736(88)91191-9. [DOI] [PubMed] [Google Scholar]
- Poulter M., Baker H. F., Frith C. D., Leach M., Lofthouse R., Ridley R. M., Shah T., Owen F., Collinge J., Brown J. Inherited prion disease with 144 base pair gene insertion. 1. Genealogical and molecular studies. Brain. 1992 Jun;115(Pt 3):675–685. doi: 10.1093/brain/115.3.675. [DOI] [PubMed] [Google Scholar]
- Prusiner S. B. Biology and genetics of prion diseases. Annu Rev Microbiol. 1994;48:655–686. doi: 10.1146/annurev.mi.48.100194.003255. [DOI] [PubMed] [Google Scholar]
- Prusiner S. B. Molecular biology of prion diseases. Science. 1991 Jun 14;252(5012):1515–1522. doi: 10.1126/science.1675487. [DOI] [PubMed] [Google Scholar]
- Rosen D. R., Siddique T., Patterson D., Figlewicz D. A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J. P., Deng H. X. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993 Mar 4;362(6415):59–62. doi: 10.1038/362059a0. [DOI] [PubMed] [Google Scholar]
- Saunders A. M., Schmader K., Breitner J. C., Benson M. D., Brown W. T., Goldfarb L., Goldgaber D., Manwaring M. G., Szymanski M. H., McCown N. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet. 1993 Sep 18;342(8873):710–711. doi: 10.1016/0140-6736(93)91709-u. [DOI] [PubMed] [Google Scholar]
- Saunders A. M., Strittmatter W. J., Schmechel D., George-Hyslop P. H., Pericak-Vance M. A., Joo S. H., Rosi B. L., Gusella J. F., Crapper-MacLachlan D. R., Alberts M. J. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993 Aug;43(8):1467–1472. doi: 10.1212/wnl.43.8.1467. [DOI] [PubMed] [Google Scholar]
- St George-Hyslop P., Haines J., Rogaev E., Mortilla M., Vaula G., Pericak-Vance M., Foncin J. F., Montesi M., Bruni A., Sorbi S. Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nat Genet. 1992 Dec;2(4):330–334. doi: 10.1038/ng1292-330. [DOI] [PubMed] [Google Scholar]
- Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., Roses A. D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1977–1981. doi: 10.1073/pnas.90.5.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tateishi J., Kitamoto T. Developments in diagnosis for prion diseases. Br Med Bull. 1993 Oct;49(4):971–979. doi: 10.1093/oxfordjournals.bmb.a072656. [DOI] [PubMed] [Google Scholar]
- Zerr I., Helmhold M., Armstrong V. W., Weber T. Apolipoprotein E in Creutzfeldt-Jakob disease. Lancet. 1995 Jan 7;345(8941):68–69. [PubMed] [Google Scholar]